← Back to patent-cliff list
奥美拉唑
Tier C — Watch / tradeOmeprazole
-
Originator
1991
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Proton pump
Brand：Nuclosina、Omepral、Parizac、Omeprazon、Emilok、Audazol、Losec、Prilosec、Antra、Omeprazone、Losec/Prilosec、Omapren、Omez、Omepradex、Mopral、Miol
Indications (approved)：胃灼痛、胃食管反流病、胃溃疡、胃酸过多、十二指肠溃疡、幽门螺杆菌感染
Regional status
US
批准上市
2009-04-02
EU
-
China
批准上市
1992-01-01
Japan
批准上市
1991-04-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Omeprazole?
Approved indications include: 胃灼痛, 胃食管反流病, 胃溃疡, 胃酸过多, 十二指肠溃疡, 幽门螺杆菌感染.
When does the Omeprazole patent expire?
No public expiry year is available for Omeprazole yet; this page updates once verified.
How do I get a quote for Omeprazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25